// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A review of the first 6 months of a digital partner notification system

Abigail Foster - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characteristics of PrEP users attending London sexual and reproductive health clinic post-lockdown

Jana Bawazir - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

HIV pre-exposure prophylaxis use amongst transgender patients attending a sexual health service

Sophie Ross - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Delivering a monthly face to face sexual health session for 3 months in an outreach setting for 16–21 year olds (up to 25 year old SEND) within a Young person’s homeless hostel and mother and baby unit with the aim to facilitate supportive access into clinical services after the trial

Alison Chorlton - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Feasibility of auditing new evidence-based partner notification outcome measures stratified by sexual partnership-type

Beth McMahon - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Re-Audit to determine the rates of triple site testing for chlamydia and gonorrhoea in men who have sex with men attending sexual health services

Ellen Heath - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Introduction of new foundation year 3 (F3) roles within an integrated sexual health service

Katarzyna Kirstein - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation of targeted testing and resistance-guided therapy for Mycoplasma genitalium in a large urban STI service

Eilidh Mitchell - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Navigating a procaine penicillin shortage: clinical outcomes in ceftriaxone-treated neurosyphilis

Hasan Mohammed - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

ceftriaxone

Impact of social media promotion on uptake of a pilot online contraception service in Northern Ireland

Justin Harbottle - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

progestogen

Unmet need for hepatitis B vaccination and PrEP among MSM using online STI testing services who are at risk of these infections

Justin Harbottle - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hepatitis B

N/A

Mystery shopping service evaluation of access to sexual health clinics in the UK, presenting with symptoms of primary genital herpes

Hannah MacCarthy - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Genital herpes

N/A

Evaluating the management of syphilis at the Cardiff Royal Infirmary (CRI) during the Covid-19 pandemic

Katherine Spofforth - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Evaluating health adviser activity and model of PrEP delivery in a post Covid-19 and NHS PrEP landscape

Tristan Griffiths - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Comparing trichomonas vaginalis clinical care before and after the COVID-19 pandemic

Lauren Grahame - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

An analysis of service users accessing a routine contraception service via an online platform during the COVID-19 pandemic

Charlotte Goward - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Effect of the COVID-19 pandemic on chlamydia testing and diagnosis within Scotland’s largest sexual health service

Rebecca Holt - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Quantifying the effect of the COVID-19 pandemic and associated interventions on HIV testing at sexual health services

Tasnuva Tabassum - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The impact of the Covid-19 pandemic on sexual health service utilisation by men who have sex with men (MSM) in England

Stephanie Migchelsen - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Evaluation of new community sexual health telephone prescribing service during COVID-19 pandemic

Teresa Snook - British Association for Sexual Health and HIV (BASHH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Copyright © 2026. QuantiNova All rights reserved